DAFTAR PUSTAKA

1. Rerknimitr P, Pongprutthipan M, Ruxrungtham K. Drug-induced hypersensitivity syndrome/drug

reaction with eosinophilia and systemic symptoms (DIHS/DRESS): 11 years retrospective study
in Thailand. Allergology International. 2016;65(1):432-438.
2. Chen YC, Chiu HC, Chu CY. Drug reaction with eosinophilia and systemic symptoms: a
retrospective study of 60 cases. Arch Dermatol. 2010;146(1):1373-9.
3. Um SJ, Lee SK, Kim YH, Kim KH, Son CH, Roh MS, et al. Clinical features of druginduced
hypersensitivity syndrome in 38 patients. J Investig Allergol Clin Immunol. 2010;20(1):556-62.
4. Pichler WJ. Drug hypersensitivity reactions: classification and relationship to T-cell activation.
Dalam: Pitchler WJ, editor (penyunting). Drug hypersensitivity. Basel: Karger;2007.hlm.168-89.
5. Jung HY, Park S, Shin B , Lee JH , Lee SJ , Lee MK, et al. Prevalence and clinical features of drug
reactions with eosinophilia and systemic symptoms syndrome caused by antituberculosis drugs:
a retrospective cohort study. AAIR. 2018;10:4168.
6. Pichler W, Yawalkar N, Schmid S, Helbling S. Allergy. Oxford: Blackwell; 2002.
7. Goon A. Pathogenesis of Adverse Drug Reactions: Immunological Versus Non-Immunological
Mechanisms. Dermatology Bulletin 2004; 24: 4–5.
8. Vanini A. Clinical Manifestation of DRESS (Drug Reaction with Eosinophilia and Systemic
Symptom) Syndrome. Departemen Ilmu Kesehatan Kulit dan Kelamin Fakultas Kedokteran
Universitas Airlangga. Rumah Sakit Umum Daerah Dr. Soetomo Surabaya. 1990

https://www.scielo.br/scielo.php?pid=S0365-05962012000300013&script=sci_arttext